These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3109340)

  • 1. A multidimensional approach to the assessment of clinical validity in a study on CCVD treatment: dihydroergocristine versus placebo.
    Fioravanti M; Buckley AE; Agnoli A
    Arch Gerontol Geriatr; 1987 Apr; 6(1):83-93. PubMed ID: 3109340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and safety of daily dosages of 6 mg and 20 mg dihydroergocristine in the treatment of chronic cerebro-vascular disease.
    Pagliano FM; Galbiati GC
    J Int Med Res; 1995; 23(4):219-27. PubMed ID: 7589764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
    Pöthig D; Sauer I; Hansen H; Weidnitzer M
    Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [One-year therapy with dihydroergocristine for treatment of impaired alertness and memory in elderly patients. Placebo-controlled multicenter study].
    Agliati G; Lazzaroni M; Mariani G; Marras F; Massetto N; Menozzi C; Ortenzi E; Perna G; Puppo N; Santambrogio S
    Arzneimittelforschung; 1992 Nov; 42(11A):1414-6. PubMed ID: 1492865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 6. Memory improvements and pharmacological treatment: a method to distinguish direct effects on memory from secondary effects due to attention improvement.
    Fioravanti M; Di Cesare F
    Int Psychogeriatr; 1992; 4(1):119-26. PubMed ID: 1391667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
    Lazzari R; Passeri M; Chierichetti SM
    Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients.
    Rousseau JJ
    Clin Ther; 1987; 9(3):267-72. PubMed ID: 3111702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiologic study on the effectiveness and safety of dihydroergocristine in impaired memory and behavioral functions in aged humans].
    Abate G; Angeleri F; Bartorelli L; Battistin L; Bergamasco B; Bertolini S; Bulfoni A; Capurso A; Cazzato G; Coccagna G
    Arzneimittelforschung; 1992 Nov; 42(11A):1417-21. PubMed ID: 1492866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
    Lazzaroni M; Cattalini C; Massetto N; Poli A
    Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol-induced organic cerebral psychosyndromes: partial reversal of cognitive impairments assisted by dihydroergocristine.
    Rainer M; Mucke HA; Chwatal K; Havelec L
    Psychopharmacology (Berl); 1996 Oct; 127(4):365-9. PubMed ID: 8923573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controlled clinical study on the activity and tolerance of Trivastan].
    Nicrosini F; Pasotti C
    Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
    Muchnik S
    Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
    [No Abstract]   [Full Text] [Related]  

  • 15. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
    Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
    Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
    Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
    Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study with dihydroergotoxine mesylate in cerebrovascular disturbances.
    Yoshikawa M; Hirai S; Aizawa T; Kuroiwa Y; Goto F; Sofue I; Toyokura Y; Yamamura H; Iwasaki Y
    J Am Geriatr Soc; 1983 Jan; 31(1):1-7. PubMed ID: 6336765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for organic brain syndrome in late life. Evaluation of an ergot derivative vs placebo.
    Gaitz CM; Varner RV; Overall JE
    Arch Gen Psychiatry; 1977 Jul; 34(7):839-45. PubMed ID: 406875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
    Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
    J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.